Discovery of a New and Selective HPK1 PROTAC for Enhancing Tumor Immunotherapy through Eliminating GLK DegradationMingfei Wu, Xiaowu Dong, Zheyuan Shen et al.|Journal of Medicinal Chemistry|2025Cited by 6